Volta Medical’s artificial intelligence (AI) solution demonstrated 83% freedom from atrial fibrillation (AF) at 12 months after a single procedure in patients with recurrent AF and isolated pulmonary veins following...
Gilde Healthcare Company Volta Medical publishes RESTART Trial Results on AI Solutions in Recurrent Atrial Fibrillation
Volta Medical’s artificial intelligence (AI) solution demonstrated 83% freedom from atrial fibrillation (AF) at 12 months after a single procedure in patients with recurrent AF and isolated pulmonary veins following...
3. February 2026
Gilde Healthcare backed MedTech Group acquires precision surgical instruments and implants contract manufacturer Rudischhauser
Gilde Healthcare’s Surgical Instrument Contract Manufacturing Group (“the Group”) has acquired Rudischhauser Surgical Instruments Manufacturing GmbH (“Rudischhauser”), marking a significant milestone in the creation of a leading contract manufacturing group...
26. January 2026
Gilde Healthcare Company Volta Medical publishes RESTART Trial Results on AI Solutions in Recurrent Atrial Fibrillation
Volta Medical’s artificial intelligence (AI) solution demonstrated 83% freedom from atrial fibrillation (AF) at 12 months after a single procedure in patients with recurrent AF and isolated pulmonary veins following...
3. February 2026
Filter & Suche
Fondsstrategie :
Loading...
Das waren alles Artikel
859657bcaa